Prabhakar Dorairaj
@prabhud19
Followers
2K
Following
8K
Media
771
Statuses
7K
Preventive Interventional Cardiologist, FACC, FESC,Member of Consensus Statement on Dyslipidemia in India,Fellow Indian Society of Hypertension
Chennai
Joined April 2011
RT @Lipidaoi1: *Call for Abstracts – LAICON International 2025*.We invite abstract submissions for oral and poster presentations at LAICON….
0
5
0
RT @ZHeart11768530: 🔴 ECG Criteria for RBBB, LBBB, LAFB & LPFB . For LBBB, you won’t be seeing “W” pattern in every ECG so criteria to rem….
0
138
0
Simple picture explaining just the weight loss with diet, medicines - oral and injectable, and surgery . I’m really impressed with tirzepatide.
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee.
0
0
0
RT @JAMACardio: Preoperative cardiovascular risk did not affect outcomes related to continuing vs discontinuing RAS inhibitors before major….
0
7
0
RT @Drlipid: For those who wish to view my lecture on the Brain and Lipids - a topic rarely taught - here is the link .
0
23
0
RT @ESC_Journals: Circadian patterns of atrial fibrillation and disease progression assessed by implanted loop recorders. Discover more in….
0
16
0
RT @MWeintraubMD: What is the impact of tirzepatide on body composition? 🤔. There was an absolute loss in lean mass 💪⬇️, however there was….
0
59
0
RT @TrackYourHeart: Cardiac Amyloidosis Diagnosis.Cardiac amyloidosis is a restrictive cardiomyopathy caused by extracellular deposition of….
0
58
0
CAC 300 =ASCVD shouldn’t it add statin naive patients.
CAC > 300 is equivalent to prior ASCVD for risk of future cardiovascular events. One could consider treating someone with CAC > 300 as SECONDARY prevention, not primary prevention. Similar risk = similar therapies. #ADA2025 #ADASciSessions
0
0
0
Congratulations @BoopathyCardio on successfully defending your public PhD viva . Best wishes and proud of you.
1
1
5
HFImp EF.
🔴 HF With Improved EF: Definitions, Epidemiology, & Management @JACCJournals #Cardiology #Cardioed #heartfailure
0
0
1
RT @ZHeart11768530: 🔴Orthostatic Hypotension: A Practical Approach⤵️ #Review #openaccess . 🔹Is defined as a decrease in blood pressure of….
0
49
0
Managing LV thrombus.
#EHJCVI 📌 What should we do with LV thrombus? 📚 This editorial explores key questions: which echo features predict resolution 🔍, how long to keep OAC 💊, how often to repeat TTE 🖥️, and what to do in case of suboptimal resolution ⚠️ Read more 👉
0
0
2
A leave out analysis showing benefits of Colchicine in secondary prevention. very interesting and new.
Colchicine for Secondary Prevention in Established ASCVD: A Systematic Review and Meta-Analysis .@AbdelazizMD1 @danilorenzatti @ashleyradparvar @ToshikiKuno @analyzeF @CarlLavie31733 @DrMarthaGulati @DLBHATTMD @virani_md @DrMichaelShapir @MontefioreNYC
0
0
1
RT @JACCJournals: "High-risk plaque,” not “vulnerable plaque”? This new #JACCIMG statement explores challenges to the concept, advances in….
0
77
0
RT @ESC_Journals: Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabet….
0
29
0
PAH management.
🔴Treatment algorithm for pulmonary arterial hypertension⤵️ #2024Review #openaccess . 🔹 #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical
0
0
1
Alcohol and heart disease - WHO says there is no safe level of intake.
🔴Alcohol Use and Cardiovascular Disease:⤵️A 2025 Scientific Statement #openaccess . 🔹 #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd
0
0
0